Cargando…
Long-Term MALT1 Inhibition in Adult Mice Without Severe Systemic Autoimmunity
The protease MALT1 is a key regulator of NF-κB signaling and a novel therapeutic target in autoimmunity and cancer. Initial enthusiasm supported by preclinical results with MALT1 inhibitors was tempered by studies showing that germline MALT1 protease inactivation in mice results in reduced regulator...
Autores principales: | Demeyer, Annelies, Driege, Yasmine, Skordos, Ioannis, Coudenys, Julie, Lemeire, Kelly, Elewaut, Dirk, Staal, Jens, Beyaert, Rudi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522757/ https://www.ncbi.nlm.nih.gov/pubmed/33083726 http://dx.doi.org/10.1016/j.isci.2020.101557 |
Ejemplares similares
-
MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner
por: Demeyer, Annelies, et al.
Publicado: (2019) -
MALT1-Deficient Mice Develop Atopic-Like Dermatitis Upon Aging
por: Demeyer, Annelies, et al.
Publicado: (2019) -
Mepazine Inhibits RANK-Induced Osteoclastogenesis Independent of Its MALT1 Inhibitory Function
por: Meloni, Laura, et al.
Publicado: (2018) -
Analysis of T cells in mouse lymphoid tissue and blood with flow cytometry
por: Skordos, Ioannis, et al.
Publicado: (2021) -
Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis
por: Mc Guire, Conor, et al.
Publicado: (2014)